Mark A. Chidel
Papers
1
Total Citations
9
H-Index
1
About
Mark A. Chidel is a leading clinical researcher in thoracic oncology, with a focused expertise in the comparative effectiveness of treatments for early-stage non–small cell lung cancer. His work centers on patient-centered outcomes, particularly the longitudinal quality of life following sublobar resection versus stereotactic body radiation therapy (SBRT). His landmark 2024 study, which has already garnered 9 citations, directly addresses a critical knowledge gap by providing comparative data on how these two common alternatives to lobectomy impact patients’ daily lives over time. This research is vital for clinicians and patients making shared decisions when surgery is not an option. Chidel’s contributions are notable for shifting the conversation from purely oncologic endpoints to the holistic, lived experience of the patient, helping to define best practices for a vulnerable population. His work is increasingly cited as a key reference in treatment guidelines and shared decision-making frameworks for early-stage lung cancer.
Research Focus
Key Achievements
Top Papers
- 1